Use of autologous human mesenchymal stromal cell/fibrin clot constructs in upper limb non-unions: long-term assessment.
<h4>Background</h4>Tissue engineering appears to be an attractive alternative to the traditional approach in the treatment of fracture non-unions. Mesenchymal stromal cells (MSCs) are considered an appealing cell source for clinical intervention. However, ex vivo cell expansion and diffe...
Main Authors: | Stefano Giannotti, Luisa Trombi, Vanna Bottai, Marco Ghilardi, Delfo D'Alessandro, Serena Danti, Giacomo Dell'Osso, Giulio Guido, Mario Petrini |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24023694/?tool=EBI |
Similar Items
-
Correction: Use of Autologous Human mesenchymal Stromal Cell/Fibrin Clot Constructs in Upper Limb Non-Unions: Long-Term Assessment
by: Stefano Giannotti, et al.
Published: (2013-01-01) -
Correction: Use of Autologous Human mesenchymal Stromal Cell/Fibrin Clot Constructs in Upper Limb Non-Unions: Long-Term Assessment.
by: Stefano Giannotti, et al.
Published: (2013-01-01) -
Microrheology of fibrin clots
by: Allan, Peter
Published: (2012) -
The clot thickens: Autologous and allogeneic fibrin sealants are mechanically equivalent in an ex vivo model of cartilage repair.
by: Rebecca M Irwin, et al.
Published: (2019-01-01) -
Fibrin Clot Formation and Lysis in Plasma
by: Julie Brogaard Larsen, et al.
Published: (2020-09-01)